Dec
01
EU funds research into causes and new therapies for multiple sclerosis
EU funds research into causes and new therapies for multiple sclerosis The progression of multiple sclerosis (MS) can usually be slowed down with medication, but a cure is currently not possible. It is now established that Epstein-Barr virus is involved in the development of MS. However, it is not known how the pathogen triggers the [...]
DETAIL
Jan
18
“The junk DNA” is able to activate immune response of T lymphocytes, the guards of the fight against cancer”
The research, coordinated by Beatrice Bodega and Sergio Abrignani, has identified for the first time a new mechanism involving RNA molecules deriving from "repeated elements" of DNA: until a few years ago considered "junk DNA", they are instead fundamental for the correct function of T lymphocytes, cells at the forefront of the fight against cancer. [...]
DETAIL
Nov
22
Antios Therapeutics Announces Agreement with IRBM, INGM and OSR to Acquire Fourth-Generation HBV Capsid Assembly Modulators (CAMs)
On November 15, 2021 – Antios Therapeutics, Inc. (“Antios”), a clinical-stage biopharmaceutical company developing innovative therapies to treat and cure chronic hepatitis B virus (HBV), announced the agreement to purchase the IP rights to a novel series of fourth-generation capsid assembly modulators (CAMs) discovered and developed jointly by IRBM, Promidis/CNCCS (a subsidiary of IRBM), Istituto [...]
DETAIL
Jul
27
New breakthrough to help immune systems in the fight against cancer
New research has identified potential treatment that could improve the human immune system’s ability to search out and destroy cancer cells within the body. Scientists have identified a way to restrict the activity a group of cells which regulate the immune system, which in turn can unleash other immune cells to attack tumours in cancer [...]
DETAIL
May
11
Merck ‘Grant for Oncology Innovation’ awards recognize recipients for pushing boundaries in oncology research
Merck today announced recipients of the fourth annual Grant for Oncology Innovation (GOI) awards. The three winners of this prestigious program were awarded €1 million in total to progress their research. Recipients of the 2017 GOI award are: Renata Maria Grifantini, National Institute of Molecular Genetics, Milan, Italy, for her proposal: “Novel targets of tumor-infiltrating CD4+ regulatory [...]
DETAIL
Mar
04
EMBL recognises the work of Raffaele De Francesco with the Lennart Philipson Award
The European Molecular Biology Laboratory (EMBL) has assigned the 2018 Lennart Philipson Award to Raffaele De Francesco, an EMBL alumnus now head of the Virology Laboratory of INGM. Raffaele De Francesco’s work on the Hepatitis C virus (HCV) led to a medical revolution. Previously, certain chronic viral infections had been kept under control using drugs, [...]
DETAIL
Dec
21
INGM among the partners of CurB: a project funded by Region Lombardy to fight chronic HBV
Luca del Gobbo, delegate for University, research and Open innovation at the Lombardy Region, signed the research agreement with Promidis srl to develop innovative drugs to fight and win the hepatitis B virus. Partners in the project are Istituto Nazionale di Genetica Molecolare-INGM, San Raffaele hospital, Univerity of Milano and Policlicnico “San Matteo” in Pavia. [...]
DETAIL
May
23
Forgeries as obstacles to change and innovation
INGM is proud to have been the host of the first "Salotto Invernizzi - INGM", on the topic "Forgeries as obstacles to change and innovation". Among others, Minister of Health Beatrice Lorenzin spoke. The discussion was moderated by Paolo Mieli. Click here to download the poster of the event. A few moments can were recorded [...]
DETAIL
